Dexcom DXCM
NASDAQ DXCM
$77.94 -0.38 (-0.49%)
At close: Oct 23, 2026 · 4:00 PM EDT

Dexcom (DXCM) Gains from Sales and Divestitures (2015 - 2016)

Updated

Dexcom (DXCM) recorded Gains from Sales and Divestitures of -$400,000 in Q3 2016, compared with -$100,000 a year earlier.

Analysis

Dexcom (DXCM) Gains from Sales and Divestitures (2015 - 2016) Analysis & Trends

On a TTM basis, Dexcom's Gains from Sales and Divestitures came in at -$700,000 as of Sep 30, 2016; for FY2010, it came in at -$100,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.17 Bn 228.32 Bn 4.88 Bn
2 Abbott Laboratories 179.42 Bn 150.51 Bn 7.27 Bn
3 Danaher 161.98 Bn 145.80 Bn 3.61 Bn
4 Intuitive Surgical 156.76 Bn 137.18 Bn 2.08 Bn
5 Medtronic 122.13 Bn 88.00 Bn 6.34 Bn
6 Stryker 117.84 Bn 103.96 Bn 4.50 Bn
7 Boston Scientific 66.19 Bn 61.20 Bn 3.85 Bn
8 Becton Dickinson 54.16 Bn 51.31 Bn 2.32 Bn
9 Edwards Lifesciences 51.35 Bn 35.47 Bn 1.35 Bn
10 Dexcom 29.41 Bn 19.73 Bn 830.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -400,000.00
Sep 30, 2015 -100,000.00
Mar 31, 2015 -200,000.00
API Access

Dexcom Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DXCM&period=max&api_key=YOUR_API_KEY